Case 1: 58-year-old man presenting with a neck mass and PSA over 500
Impact of combined androgen blockade
Antiandrogen withdrawal response
Prostate Cancer Journal Club

• Feasibility Study: Watchful waiting for localized low-to intermediate- grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression
• Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: When should we stop?

Select publications

Prostate cancer treatment patterns from the CaPSURE database
Primary hormonal therapy for prostate cancer
Management of patients with biochemical relapse
Management of patients with high-risk prostate cancer
Case 2: 49-year-old man with Gleason 4+3 prostate cancer
Select publications

Multimodality approach to prostate cancer
Patients’ wishes to avoid postsurgical radiation therapy
Decision-making process about adjuvant hormonal therapy
Antiandrogen monotherapy
Select publications

Prostate Cancer Journal Club

• Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis
• Osteoporosis in men treated with androgen deprivation therapy for prostate cancer
• Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy

Select publications